The network pharmacology prediction and experiment validation of Astragalus membranaceus for alleviating silicosis fibrosis via decreasing MMP9 and EGFR expression

1. Leung, C. C., Yu, I. T. & Chen, W. Silicosis. Lancet 379, 2008–2018 (2012).

   Google Scholar 

2. Jamshidi, P. et al. Silicosis and tuberculosis: A systematic review and meta-analysis. Pulmonology 31, 2416791 (2025).

   Google Scholar 

3. Liu, X., Jiang, Q., Wu, P., Han, L. & Zhou, P. Global incidence, prevalence and disease burden of silicosis: 30 years’ overview and forecasted trends. BMC Public Health 23, 1366 (2023).

   Google Scholar 

4. Fernández Álvarez, R. et al. Guidelines for the diagnosis and monitoring of silicosis. Arch. Bronconeumol. 51, 86–93 (2015).

   Google Scholar 

5. McEwen, K. & Brodie, L. Lung transplantation for silicosis and recovery: An Australian case study. Br. J. Nurs. 30, 178–183 (2021).

   Google Scholar 

6. Dong, N. et al. Astragalus polysaccharides alleviates LPS‐induced inflammation via the NF‐κB/MAPK signaling pathway. J. Cell. Physiol. 235, 5525–5540 (2020).

   Google Scholar 

7. Dong, M., Li, J., Yang, D., Li, M. & Wei, J. Biosynthesis and pharmacological activities of flavonoids, triterpene saponins and polysaccharides derived from *Astragalus membranaceus*. Molecules https://doi.org/10.3390/molecules28135018 (2023).

   Google Scholar 

8. Zhang, X., Qu, X. & Zou, Y. The effect of astragalus on humoral and cellular immune response: A systematic review and meta-analysis of human studies. Complement. Med. Res. 30, 535–543 (2023).

   Google Scholar 

9. Dan, L. et al. Efficacy and potential mechanisms of the main active ingredients of Astragalus mongholicus in animal models of liver fibrosis: A systematic review and meta-analysis. J. Ethnopharmacol. 319, 117198 (2024).

   Google Scholar 

10. Li, X. et al. Network pharmacology approaches for research of Traditional Chinese Medicines. Chin. J. Nat. Med. 21, 323–332 (2023).

    Google Scholar 

11. Sahu, D. et al. A review on molecular docking as an interpretative tool for molecular targets in disease management. Assay Drug Dev. Technol. 22, 40–50 (2024).

    Google Scholar 

12. Dasgupta, S. Identification and molecular modelling of potential drugs targeting the genes involved in the progression of lung cancer in patients with idiopathic pulmonary fibrosis. Gene Rep. 37, 102067 (2024).

    Google Scholar 

13. Li, N. et al. Bioinformatic analysis of differentially expressed genes and pathways in idiopathic pulmonary fibrosis. Annals Trans. Med. 9, 1459 (2021).

    Google Scholar 

14. Wu, Z. et al. Identifying potential biomarkers of idiopathic pulmonary fibrosis through machine learning analysis. Sci. Rep. 13, 16559 (2023).

    Google Scholar 

15. Sun, W. et al. ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1. Cell. Mol. Biol. Lett. 27, 26 (2022).

    Google Scholar 

16. Du, Y., Huang, F., Guan, L. & Zeng, M. Role of PI3K/Akt/mTOR pathway-mediated macrophage autophagy in affecting the phenotype transformation of lung fibroblasts induced by silica dust exposure. Zhongnan Daxue Xuebao (Yixue Ban) 48, 1152–1162 (2023).

    Google Scholar 

17. Kasai, H., Allen, J. T., Mason, R. M., Kamimura, T. & Zhang, Z. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir. Res. 6, 56 (2005).

    Google Scholar 

18. Cheng, W. H. et al. Amphiregulin induces CCN2 and fibronectin expression by TGF-β through EGFR-dependent pathway in lung epithelial cells. Respir. Res. 23, 381 (2022).

    Google Scholar 

19. Zhang, Y. et al. Astragali radix (Huangqi): A time-honored nourishing herbal medicine. Chin. Med. 19, 119 (2024).

    Google Scholar 

20. Ru, J. et al. TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. J. Cheminform. 6, 13 (2014).

    Google Scholar 

21. Cao, Z. et al. A novel pathophysiological classification of silicosis models provides some new insights into the progression of the disease. Ecotoxicol. Environ. Saf. 202, 110834 (2020).

    Google Scholar 

22. Barabási, A. L. & Oltvai, Z. N. Network biology: Understanding the cell’s functional organization. Nat. Rev. Genet. 5, 101–113 (2004).

    Google Scholar 

23. Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947–1951 (2019).

    Google Scholar 

24. Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53, D672-d677 (2025).

    Google Scholar 

25. Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000).

    Google Scholar 

26. Mondal, J., Friesner, R. A. & Berne, B. J. Role of desolvation in thermodynamics and kinetics of ligand binding to a kinase. J. Chem. Theory Comput. 10, 5696–5705 (2014).

    Google Scholar 

27. Wabik, J., Kurcinski, M. & Kolinski, A. Coarse-grained modeling of peptide docking associated with large conformation transitions of the binding protein: Troponin I fragment-Troponin C system. Molecules 20, 10763–10780 (2015).

    Google Scholar 

28. Ivanov, K. I. et al. Phosphorylation regulates FOXC2-mediated transcription in lymphatic endothelial cells. Mol. Cell. Biol. 33, 3749–3761 (2013).

    Google Scholar 

29. Liu, Z. et al. MicroRNA-146a negatively regulates PTGS2 expression induced by Helicobacter pylori in human gastric epithelial cells. J. Gastroenterol. 48, 86–92 (2013).

    Google Scholar 

30. Huang, M. et al. Quercetin: A flavonoid with potential for treating acute lung injury. Drug Des. Devel. Ther. 18, 5709–5728 (2024).

    Google Scholar 

31. Kim, M. et al. Quercetin and isorhamnetin attenuate benzo[a]pyrene-induced toxicity by modulating detoxification enzymes through the AhR and NRF2 signaling pathways. Antioxidants (Basel) 10, 787 (2021).

    Google Scholar 

32. Sharma, A. & Wairkar, S. Flavonoids for treating pulmonary fibrosis: Present status and future prospects. Phytother. Res. 38, 4406–4423 (2024).

    Google Scholar 

33. Yang, D., Wang, T., Long, M. & Li, P. Quercetin: Its main pharmacological activity and potential application in clinical medicine. Oxid. Med. Cell Longev. 2020, 8825387 (2020).

    Google Scholar 

34. Espindola, M. S. et al. Differential responses to targeting matrix metalloproteinase 9 in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 203, 458–470 (2021).

    Google Scholar 

35. Dülger, S. U., Mutlu, N., Ceylan, İ & Özhan, E. The relationship between lung fibrosis, the epidermal growth factor receptor, and disease outcomes in COVID-19 pneumonia: A postmortem evaluation. Clin. Exp. Med. 23, 1181–1188 (2023).

    Google Scholar 

36. Li, T., Yang, X., Xu, H., Liu, H. & Moitra, S. Early identification, accurate diagnosis, and treatment of silicosis. Can. Respir. J. 2022, 1–6 (2022).

    Google Scholar 

37. You, Y., Yuan, H., Min, H., Li, C. & Chen, J. Fibroblast-derived CXCL14 aggravates crystalline silica–induced pulmonary fibrosis by mediating polarization and recruitment of interstitial macrophages. J. Hazard. Mater. 460, 132489 (2023).

    Google Scholar 

38. Du, Q. et al. Therapeutic effect of Astragali Radix extract injection combined with bone marrow mesenchymal stem cells in Bleomycin-induced pulmonary fibrotic rats. Evid. Based Complement. Altern. Med. 2022, 1–12 (2022).

    Google Scholar 

39. Liu, N. et al. Isorhamnetin inhibits liver fibrosis by reducing autophagy and inhibiting extracellular matrix formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK pathways. Mediators Inflamm 2019, 6175091 (2019).

    Google Scholar 

40. Chen, J. et al. Kaempferol attenuates macrophage M1 polarization and liver fibrosis by inhibiting mitogen-activated protein kinase/nuclear factor κB signaling pathway. J. Pharmacol. Exp. Ther. 392, 103533 (2025).

    Google Scholar 

41. Cuijpers, I. et al. Quercetin, kaempferol and capsaicin counteract the TGF-β1-induced upregulation of αSMA and collagen in myoblasts. Int. J. Mol. Sci. https://doi.org/10.3390/ijms26115151 (2025).

    Google Scholar 

42. Wang, Q., Wang, F., Li, X., Ma, Z. & Jiang, D. Quercetin inhibits the amphiregulin/EGFR signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in obstructive nephropathy. Phytother. Res. 37, 111–123 (2023).

    Google Scholar 

43. Li, X. et al. The flavonoid Quercetin ameliorates liver inflammation and fibrosis by regulating hepatic macrophages activation and polarization in mice. Front. Pharmacol. 9, 72 (2018).

    Google Scholar 

44. Wu, X. et al. Use quercetin for pulmonary fibrosis: A preclinical systematic review and meta-analysis. Inflammopharmacology https://doi.org/10.1007/s10787-025-01678-1 (2025).

    Google Scholar 

45. Liu, X., Liang, Q., Qin, Y., Chen, Z. & Yue, R. Advances and perspectives on the anti-fibrotic mechanisms of the Quercetin. Am. J. Chin. Med. 53, 1411–1440 (2025).

    Google Scholar 

46. Alharbi, H. O. A., Alshebremi, M., Babiker, A. Y. & Rahmani, A. H. The role of quercetin, a flavonoid in the management of pathogenesis through regulation of oxidative stress, inflammation, and biological activities. Biomolecules https://doi.org/10.3390/biom15010151 (2025).

    Google Scholar 

47. Talbott, H. E., Mascharak, S., Griffin, M., Wan, D. C. & Longaker, M. T. Wound healing, fibroblast heterogeneity, and fibrosis. Cell Stem Cell 29, 1161–1180 (2022).

    Google Scholar 

48. Seki, E. et al. TLR4 enhances TGF-β signaling and hepatic fibrosis. Nat. Med. 13, 1324–1332 (2007).

    Google Scholar 

49. Szabo, G., Mandrekar, P. & Dolganiuc, A. Innate immune response and hepatic inflammation. Semin. Liver Dis. 27, 339–350 (2007).

    Google Scholar 

50. Wang, M. et al. Gefitinib and fostamatinib target EGFR and SYK to attenuate silicosis: A multi-omics study with drug exploration. Signal Transduct. Target. Ther. 7, 157 (2022).

    Google Scholar 

51. Peng, L. et al. Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial–mesenchymal transition and inflammation. Cell Death Dis. 11, 978 (2020).

    Google Scholar 

52. Li, G. et al. Macrophage-secreted TSLP and MMP9 promote bleomycin-induced pulmonary fibrosis. Toxicol. Appl. Pharmacol. 366, 10–16 (2019).

    Google Scholar 

53. Geng, F. et al. Quercetin alleviates pulmonary fibrosis in mice exposed to silica by inhibiting macrophage senescence. Front. Pharmacol. 13, 912029 (2022).

    Google Scholar 

54. Hao, X. et al. Inhibition of oncogenic Src ameliorates silica-induced pulmonary fibrosis via PI3K/AKT pathway. Int. J. Mol. Sci. https://doi.org/10.3390/ijms24010774 (2023).

    Google Scholar 

55. Lv, W. et al. Circular RNA CircCOL5A1 sponges the MiR-7-5p/Epac1 axis to promote the progression of keloids through regulating PI3K/Akt signaling pathway. Front. Cell Dev. Biol. 9, 626027 (2021).

    Google Scholar 

56. Yong, S., Guo, Y., Chen, X., Xu, Y. & Hu, Y. [Mechanism of IL-17 signaling pathway in spleen inflammatory response induced by altitude hypoxia in mice]. Sichuan Da Xue Xue Bao Yi Xue Ban 55, 118–124 (2024).

    Google Scholar 

57. Park, H. B. & Baek, K. H. E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers. Biochim. Biophys. Acta Rev. Cancer 1877, 188736 (2022).

    Google Scholar 

58. Long, L. et al. Mefunidone alleviates silica-induced inflammation and fibrosis by inhibiting the TLR4-NF-κB/MAPK pathway and attenuating pyroptosis in murine macrophages. Biomed. Pharmacother. 178, 117216 (2024).

    Google Scholar 

59. Schramm, F., Schaefer, L. & Wygrecka, M. EGFR signaling in lung fibrosis. Cells https://doi.org/10.3390/cells11060986 (2022).

    Google Scholar 

60. Siddika, T. et al. Delivery of active AKT1 to human cells. Cells https://doi.org/10.3390/cells11233834 (2022).

    Google Scholar 

61. Nie, Y. et al. Akt1 regulates pulmonary fibrosis via modulating IL-13 expression in macrophages. Innate Immun. 25, 451–461 (2019).

    Google Scholar 

62. Leppä, S. & Bohmann, D. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene 18, 6158–6162 (1999).

    Google Scholar 

63. Li, Y. et al. GSDME-mediated pyroptosis promotes inflammation and fibrosis in obstructive nephropathy. Cell Death Differ. 28, 2333–2350 (2021).

    Google Scholar 

64. Jiang, H. et al. Exploring the role and mechanism of Astragalus membranaceus and radix paeoniae rubra in idiopathic pulmonary fibrosis through network pharmacology and experimental validation. Sci. Rep. 13, 10110 (2023).

    Google Scholar 

Download references